These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34162033)

  • 41. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.
    Cohen M; Harrington J; Narang I; Hamilton J
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):212-5. PubMed ID: 25495188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
    Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
    J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of 5 years growth hormone treatment in patients with Prader-Willi syndrome.
    Obata K; Sakazume S; Yoshino A; Murakami N; Sakuta R
    J Pediatr Endocrinol Metab; 2003 Feb; 16(2):155-62. PubMed ID: 12713251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.
    Lin HY; Lin SP; Tsai LP; Chao MC; Chen MR; Chuang CK; Huang CY; Tsai FJ; Chou IC; Chiu PC; Huang CH; Yen JL; Lin JL; Kuo PL
    J Chin Med Assoc; 2008 Jun; 71(6):305-9. PubMed ID: 18567561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of growth hormone therapy in adults with Prader-Willi syndrome: A systematic review.
    Frixou M; Vlek D; Lucas-Herald AK; Keir L; Kyriakou A; Shaikh MG
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):645-655. PubMed ID: 33296095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.
    Cadoudal T; Buléon M; Sengenès C; Diene G; Desneulin F; Molinas C; Eddiry S; Conte-Auriol F; Daviaud D; Martin PG; Bouloumié A; Salles JP; Tauber M; Valet P
    Int J Obes (Lond); 2014 Sep; 38(9):1234-40. PubMed ID: 24406482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome.
    Trueba-Timmermans DJ; Grootjen LN; Juriaans AF; Mahabier EF; Kerkhof GF; Rings EHHM; Hokken-Koelega ACS
    Eur J Endocrinol; 2023 Jul; 189(1):132-139. PubMed ID: 37440711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index.
    Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE
    Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
    Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.
    Carrel AL; Moerchen V; Myers SE; Bekx MT; Whitman BY; Allen DB
    J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
    McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
    J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth hormone secretion and its effect on height in pediatric patients with different genotypes of Prader-Willi syndrome.
    Oto Y; Obata K; Matsubara K; Kozu Y; Tsuchiya T; Sakazume S; Yoshino A; Murakami N; Ogata T; Nagai T
    Am J Med Genet A; 2012 Jun; 158A(6):1477-80. PubMed ID: 22585665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benefit of early commencement of growth hormone therapy in children with Prader-Willi syndrome.
    Nyunt O; Harris M; Hughes I; Huynh T; Davies PS; Cotterill AM
    J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1151-8. PubMed ID: 20333875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adults with Prader-Willi syndrome have weaker bones: effect of treatment with GH and sex steroids.
    Longhi S; Grugni G; Gatti D; Spinozzi E; Sartorio A; Adami S; Fanolla A; Radetti G
    Calcif Tissue Int; 2015 Feb; 96(2):160-6. PubMed ID: 25577526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy.
    Eiholzer U; l'Allemand D; van der Sluis I; Steinert H; Gasser T; Ellis K
    Horm Res; 2000; 53(4):200-6. PubMed ID: 11044804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of growth hormone therapy on cardiac dimensions in children and adolescents with Prader-Willi syndrome.
    Hauffa BP; Knaup K; Lehmann N; Neudorf U; Nagel B
    Horm Res Paediatr; 2011; 75(1):56-62. PubMed ID: 20924154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.